High Acuity News Today

Ranger Investment Management L.P. increased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 198,476 shares of the health services provider’s stock after purchasing an additional 1,155 shares during the period. […]

Principal Financial Group Inc. cut its holdings in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119,771 shares of the health services provider’s stock after selling 563 shares during the quarter. Principal Financial Group […]

StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report published on Saturday morning. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 target price on shares of Amedisys in […]

StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. A number of other brokerages also recently issued reports on AMED. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 price target on shares of Amedisys in a research report […]

Cantor Fitzgerald restated their neutral rating on shares of Amedisys (NASDAQ:AMED – Free Report) in a report released on Thursday morning, Benzinga reports. The firm currently has a $101.00 price objective on the health services provider’s stock. Several other equities research analysts have also commented on the stock. StockNews.com started coverage on shares of Amedisys […]

Amedisys (NASDAQ:AMED – Get Free Report) released its quarterly earnings results on Wednesday. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01, Briefing.com reports. The firm had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. Amedisys […]

Amedisys (NASDAQ:AMED – Get Free Report) issued its earnings results on Wednesday. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01, Briefing.com reports. The business had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. Amedisys had a […]

Amedisys (NASDAQ:AMED – Get Free Report) announced its earnings results on Wednesday. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01, Briefing.com reports. The company had revenue of $571.41 million for the quarter, compared to analysts’ expectations of $565.38 million. Amedisys had a positive return on […]

Wolverine Asset Management LLC raised its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 13.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 35,181 shares of the health services provider’s stock after buying an additional 4,299 shares during the period. Wolverine Asset Management […]

StockNews.com began coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note issued to investors on Sunday. The brokerage issued a buy rating on the health services provider’s stock. Several other analysts also recently weighed in on AMED. Royal Bank of Canada upped their price objective on Amedisys from $97.00 to $100.00 […]